© 2020 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
R&D/Clinical Trials
Central Focus: Targeting Unmet Need in CNS
July 09, 2020
Former physician and clinical researcher Antony Loebel, now president and CEO of Sunovion Pharmaceuticals, discusses his career-long mission to advance novel treatments for patients suffering from serious and underserved CNS disorders.
Global Regulatory Collaborations Aim to Speed Access to New Vaccines & Drugs
June 29, 2020
The need for treatments to combat the spread of COVID-19 is promoting greater cooperation among drug regulatory authorities around the world, with FDA officials communicating more frequently with their counterparts in Europe, Canada, Japan and other nations through established programs and agreements.
Tackling a "Genius Virus": Dr Patrick Soon-Shiong
June 15, 2020
Physician, company CEO, surgeon, philanthropist, and owner of the LA Times, Dr. Patrick Soon-Shiong talks about his progress developing a COVID-19 treatment and his goal to produce a billion doses to tackle the virus worldwide.
Spotlight on Science Gives Public New Perspective
June 10, 2020
As government turns to the pharma industry not just for therapies or a vaccine but for tests and data to evaluate these treatments, people are receiving an education.
Cancer Patients Can Not Afford To Put Their Struggle on Hold
June 09, 2020
With widescale collaboration among companies, academia, and the science community to solve COVID-19, we can hope that this crisis has acted as a catalyst to increase positive perception for the biopharma industry.
Vaccine Production Key to Global Pandemic Response
May 17, 2020
Biopharma companies have been working overtime to supply billions of doses of any safe and effective preventive. But the tight timeframe means they can't wait for final clinical test results to begin preparing large-scale manufacturing operations and to address critical supply chain issues.
Drug Development in Wartime: Driving Tomorrow's R&D Decisions with Today's COVID-19 Data
May 10, 2020
The only way for pharma companies to know where to focus their COVID-19 R&D efforts is for the industry to have access to real-time, real-world evidence of what’s working to keep people alive, write Travis Leonardi and William Kirsh.
COVID-19: Testing Biotech's Ingenuity in New Ways
May 07, 2020
Startup biotechs need to ensure that life-changing and potentially lifesaving treatments continue to be developed in in the midst of the COVID-19 pandemic. Ohana Biosciences' Amber Salzman outlines how her company is
COVID-19 and the Evolving Science of Pharmacogenomics
April 28, 2020
Initial studies pointing to how genetic variations can impact disease states such as COVID-19 help to illustrate the growing importance of genomic medicine, writes Mark. J. Stevens.
Evolution of Prostate Cancer Treatment Gathers Speed
April 06, 2020
Amy Butcher evaluates the current treatment options for prostate cancer and the looks to the future as clinical outcomes evolve.